Alto Neuroscience
ANRO
53 hedge funds and large institutions have $245M invested in Alto Neuroscience in 2024 Q1 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
59.42% more ownership
Funds ownership: 0% → 59.42% (+59%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWG
Alpha Wave Global
New York
|
+$58M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.8M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$21.7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$17.6M |
| 5 |
7IH
72 Investment Holdings
Stamford,
Connecticut
|
+$10.5M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WWM
51
Wolff Wiese Magana
Carslbad,
California
| $11.2K | +$11.4K | +730 | New |
|
52
Wells Fargo
San Francisco,
California
| $998 | +$1.02K | +65 | New |
|
53
Macquarie Group
Sydney, NSW 2000,
Australia
| $7 | +$7.4K | +473 | New |
|
ANRO Hedge Fund Activity: Q1 2024 in Review
53 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Alto Neuroscience (ANRO) for Q1 2024, worth a combined $245M.
Buyers outnumbered sellers: 53 funds opened new ANRO positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Alpha Wave Global, opening a new position worth an estimated $58M.
- 53 institutional investors held Alto Neuroscience (ANRO) as of Q1 2024, up from 0 in Q4 2023.
- Funds reported $245M of Alto Neuroscience stock for Q1 2024.
- 53 funds opened new Alto Neuroscience positions in Q1 2024 and 0 closed out, a net change of +53 holders.
- The largest Alto Neuroscience buyer in Q1 2024 was Alpha Wave Global, an estimated $58M added.
Based on aggregated 13F filings for Q1 2024.